Maravai LifeSciences
MRVI
$7.70
Share price
1.58%
Change (1 day)
-44.16%
Change (1 year)
Categories
Maravai LifeSciences (MRVI) - P/B ratio
P/B ratio as of April 2024 : 2.45
According to Maravai LifeSciences
's latest financial reports the company has a price-to-book ratio of 2.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Maravai LifeSciences - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.08 | -48.35% |
| 2022-12-31 | 4.03 | -60.06% |
| 2021-12-31 | 10.1 | -42.35% |
| 2020-12-31 | 17.5 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.63 | -33.48% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | 93.25% | 🇬🇧 UK |
 Novavax NVAX | -0.7984 | -132.58% | 🇺🇸 USA |
 Novocure
NVCR | 3.75 | 53.04% | Jersey |